Epicardial Substrate and Outcome With Epicardial Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia | Zendy

Fermin C. García | Zendy; Víctor Bazán | Zendy; Erica S. Zado | Zendy; JianFang Ren | Zendy; Francis E. Marchlinski | Zendy

Open Access

Epicardial Substrate and Outcome With Epicardial Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia

Author(s) -

Fermin C. García,

Víctor Bazán,

Erica S. Zado,

JianFang Ren,

Francis E. Marchlinski

Publication year - 2009

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.108.834903

Subject(s) - medicine , cardiology , arrhythmogenic right ventricular dysplasia , ventricular tachycardia , cardiomyopathy , ablation , dysplasia , heart failure

Efficacy of endocardial ventricular tachycardia (VT) ablation in arrhythmogenic right ventricular cardiomyopathy/dysplasia may be limited by epicardial VT, right ventricular thickening, or both. We sought to characterize the endocardial versus epicardial substrate, measure right ventricular free wall thickness, and determine epicardial ablation efficacy in patients with right ventricular cardiomyopathy/dysplasia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research